NICHOLAS HAGANDORA: Open Payments
NPI 1205428893 · CONWAY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 27 payments from 11 companies in 2025. Trend: 2023 $710 · 2024 $519 · 2025 $563
Food & beverage: $563
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $87 |
| PFIZER INC. | 3 | $74 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $67 |
| Alnylam Pharmaceuticals Inc. | 3 | $66 |
| Novo Nordisk Inc | 2 | $58 |
| Boston Scientific Corporation | 2 | $53 |
| E.R. Squibb & Sons, L.L.C. | 3 | $43 |
| BIOTRONIK INC. | 2 | $38 |
| Daiichi Sankyo Inc. | 1 | $28 |
| ABIOMED | 1 | $27 |
Products named: LEQVIO, VYNDAQEL, LifeVest, Wegovy, CDS - MCT/CEM Monitoring, ONPATTRO, Selectra, ELIQUIS.
Industry payments across SC — which companies pay providers there.
